Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

Regina Dittmann, David Coghill, Péter Nagy et al.|CNS Drugs|2013

Cited by 88